Rhode Island 2025 Regular Session

Rhode Island House Bill H5026

Introduced
1/10/25  

Caption

Caps amount payable for 30 day supply of equipment/supplies for insulin administration/glucose monitoring at $25 or equipment designed to last more than 30 days with no deductible commencing January 1, 2026.

Impact

The bill fundamentally amends existing insurance regulations as stipulated under Chapter 27-18 of the General Laws related to accident and sickness insurance policies. It requires health insurance plans issued or renewed in Rhode Island to provide coverage for certain diabetes-related equipment, including blood glucose monitors, insulin syringes, and pumps. This legislative change could substantially improve healthcare access for diabetic patients, particularly those who may face financial barriers due to high out-of-pocket costs for these supplies. The effective date of January 1, 2026, suggests a planned implementation to allow health plans time to adjust their policies accordingly.

Summary

House Bill H5026 aims to address the high costs associated with diabetes management by capping the amount a covered person needs to pay for insulin administration and glucose monitoring supplies. Specifically, the bill mandates that from January 1, 2026, individuals will pay no more than $25 for a 30-day supply of the necessary equipment and supplies. Importantly, this coverage will not have any deductible, promoting better access to critical diabetes management resources for those affected by this condition. The bill is a significant legislative step towards making diabetes care more financially accessible for residents of Rhode Island.

Contention

While the bill enjoys support from various healthcare advocates who assert that it alleviates financial distress on individuals managing diabetes, there may be potential contention surrounding its implementation. Concerns may arise regarding how this cap will affect overall insurance premiums or whether it could lead to coverage limitations in other areas. Additionally, while the bill is designed to improve affordability, it will require health plans to adjust to regulatory changes that ensure compliance with the new cost cap, potentially inciting discussions around the sustainability of such mandates in the long term.

Companion Bills

No companion bills found.

Previously Filed As

RI H5628

Mandates all health insurance contracts, plans, or policies provide the same reimbursement to independent healthcare facilities as that of hospital affiliated facilities where the same healthcare service is provided.

RI H5082

Limits copays, coinsurance or office deductibles for services of a physical therapist to the amount authorized for the services of a primary care physician or osteopath on or after January 1, 2026.

RI S0051

Limits copays, coinsurance or office deductibles for services of a physical therapist to the amount authorized for the services of a primary care physician or osteopath on or after January 1, 2026.

RI H6158

Mandates insurance coverage for scalp cooling treatments for breast cancer patients undergoing chemotherapy to prevent hair loss during chemotherapy treatments.

RI S0263

Requires coverage for acute mental health crisis mobile response and stabilization services to eligible individuals enrolled as plan beneficiaries.

RI H6118

Requires coverage for acute mental health crisis mobile response and stabilization services to eligible individuals enrolled as plan beneficiaries.

RI S0115

Requires health plans that provide prescription benefits to cover at least one type of glucagon auto-injector, nasal spray, or formulation that does not require reconstitution to treat hypoglycemia. No copayment or deductible would be required.

RI H5173

Requires health plans that provide prescription benefits to cover at least one type of glucagon auto-injector, nasal spray, or formulation that does not require reconstitution to treat hypoglycemia. No copayment or deductible would be required.

Similar Bills

RI S0196

Caps amount payable for 30 day supply of equipment/supplies for insulin administration/glucose monitoring at $25 or equipment designed to last more than 30 days with no deductible commencing January 1, 2026.

TX SB1560

Relating to the regulation of chemical dependency treatment facilities and certain other facilities.

HI SB708

Relating To Prescriptive Authority For Clinical Psychologists.

AZ HB2250

AHCCCS; preventative dental care

AZ SB1207

AHCCCS; speech therapy; cochlear implants

AZ SB1347

AHCCCS; comprehensive dental care

TX HB2995

Relating to the prescribing of medical cannabis for medical use to certain veterans with combat-related injuries or medical conditions and the licensing of dispensing organizations under the Texas Compassionate Use Program.

TX HB915

Relating to the administration and monitoring of health care provided to foster children.